Eydo Pharma's mission is to provide effective, innovative therapies for a major global unmet need: combatting infections caused by resistant bacteria.
We believe our patient-focused, yet technologically ambitious vision, will only succeed by combining our years of natural products know-how with first-in-class technologies and processes. We strive for applying this principle to all aspects of our activities.
Our lead compound EP1012 has a unique set of properties that make it an ideal antibacterial candidate and in addition, Eydo Pharma has developed a pipeline of earlier innovative compounds with significant potential as antimicrobial therapies worldwide.
Pr Jacques Samarut, PhD
President & CSO Eydo Pharma